-
AstraZeneca lung cancer targeted drug Teresa has been approved for new indications in China
AstraZeneca announced on June 26 that the National Medical Products Administration of China officially approved Teresa& on June 18, 2024; reg; The combination of pemetrexed and platinum based chemoth ...